The aim of this study was to compare immigrant and Swedish patients with heart failure (HF) regarding symptoms, diagnosis, medical treatment, discharge planning, readmission and mortality. The method was descriptive and retrospective using an audit protocol to review data from 214 medical records of 107 immigrants and 107 Swedish patients hospitalised for HF or chronic heart failure during 1994-2003. Descriptive statistics and significance testing were performed. Few differences between the patient groups were observed. Significantly larger number of immigrants were referred to the nurse-led HF clinic follow-up visits (P = 0.026). Significantly more immigrants had ischemic heart disease on admission (P = 0.025) and were prescribed short-acting nitrates at discharge (P = 0.026). More Swedes were prescribed medications for insomnia (P = 0.029). More immigrants than Swedes are referred to HF clinic after discharge, suggesting that physicians rely on specialised nurses to provide follow-ups, tailored to the needs of immigrant patients. The study indicates that the Swedish health care system has achieved its aim of equality in the care and treatment of this patient group. Further studies are needed to determine if this also applies to the quality of the provided care and treatment. © 2007 European Society of Cardiology.

Diagnose Immigrant Discharge Heart failure Symptom Treatment

medical record review Patient Readmission descriptive research immigrant clopidogrel hospital patient hospitalization warfarin nurse beta adrenergic receptor blocking agent hospital discharge follow up Patient Discharge acetylsalicylic acid priority journal Aged Medical Audit health care distribution statistical significance prescription insomnia Sweden Humans Physician's Practice Patterns drug utilization nitrate diuretic agent Emigrants and Immigrants female antithrombocytic agent male vasodilator agent Matched-Pair Analysis anticoagulant agent Referral and Consultation symptom Article Retrospective Studies hydroxymethylglutaryl coenzyme A reductase inhibitor dipeptidyl carboxypeptidase inhibitor Cardiovascular Agents hospital readmission ischemic heart disease sedative agent retrospective study heart failure mortality Health Services Accessibility